Adverse Effects of Antiepileptic Drugs
- 1 February 2000
- Vol. 41 (s2) , S42-S52
- https://doi.org/10.1111/j.1528-1157.2000.tb01523.x
Abstract
Summary: Because the efficacies of antiepileptic drugs (AEDs) are often equivalent, selection of an AED is often determined by adverse effects. Differences in methods for labeling adverse effects and in the adverse effect terms themselves, variations in the populations studied, and inconsistent classifications of adverse effects make it difficult to know how to use information on adverse effects to choose an AED. Effort is underway to develop more extensive and internationally acceptable descriptive terms for adverse effects. Comparison of adverse effects in patients taking AEDs with adverse events in control groups is helpful; however, data from controlled studies are often lacking for most AEDs. Because of these limitations, the clinician must adopt a preventative and early detection approach based on some general principles. This review outlines factors to consider for avoiding and detecting AED adverse effects. The occurrence of weight change with AEDs is reviewed extensively, serving to illustrate how the principle factors can be used to avoid and manage adverse effects and where there is need for better studies of the short‐ and long‐term adverse effects of AEDs.Keywords
This publication has 74 references indexed in Scilit:
- Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind studyThe Lancet, 1999
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999
- TopiramateClinical Pharmacokinetics, 1998
- Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trialThe Italian Journal of Neurological Sciences, 1996
- Bodyweight Change as an Adverse Effect of Drug TreatmentDrug Safety, 1996
- The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicityPharmacology & Therapeutics, 1995
- Efficacy of felbamate in therapy for partial epilepsy in childrenThe Journal of Pediatrics, 1994
- Felbamate in the Treatment of Lennox‐Gastaut Syndrome: Results of a 12‐Month Open‐Label Study Following a Randomized Clinical TrialEpilepsia, 1993
- Hazards of Inference: The Active Control InvestigationEpilepsia, 1989
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985